CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000).
Navarro, F
CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). [electronic resource] - The Journal of antimicrobial chemotherapy Sep 2001 - 383-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0305-7453
10.1093/jac/48.3.383 doi
Anti-Bacterial Agents--pharmacology
Drug Resistance, Bacterial--physiology
Drug Resistance, Multiple--physiology
Enterobacteriaceae--enzymology
Escherichia coli--drug effects
Humans
Klebsiella--drug effects
Klebsiella pneumoniae--drug effects
Proteus mirabilis--drug effects
Salmonella enterica--drug effects
Spain
beta-Lactamases--metabolism
CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). [electronic resource] - The Journal of antimicrobial chemotherapy Sep 2001 - 383-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0305-7453
10.1093/jac/48.3.383 doi
Anti-Bacterial Agents--pharmacology
Drug Resistance, Bacterial--physiology
Drug Resistance, Multiple--physiology
Enterobacteriaceae--enzymology
Escherichia coli--drug effects
Humans
Klebsiella--drug effects
Klebsiella pneumoniae--drug effects
Proteus mirabilis--drug effects
Salmonella enterica--drug effects
Spain
beta-Lactamases--metabolism